Autologous ADSCs for chronic kidney disease

2020-03-18 12:11:09 admin
Autologous ADSCs for chronic kidney disease 

Mr. Liu, 65 years old, has a history of glomerulonephritis for 35 years  

Mr. Liu suffered glomerulonephritis 35 years ago. After the treatment, the necrosis of the left hip joint incurred, and he walked on a crutch after a joint fusion in unbearable pain. He heard that autologous stem cells that can repair and treat glomerulonephritis, and decided to have a try upon multiple consultations. 

Intervention treatment of autologous ADSCs is as follows: 

In April 2016, 100ml fat was extracted, and 300 million autologous ADSCs were obtained in collaboration with Magellan Lab after 6 weeks of Australian TGA certification. Australian licensed medical experts developed an exclusive anti-aging program for him with 300 million autologous ADSCs. 100 million autologous ADSCs were divided into 4 parts for intravenous transplantation within one year to perform systemic function intervention for anti-aging repair; the rest 200 million autologous ADSCs were divided into 4 injections into the cavity on the right hip joint within one years. Mr. Liu's spontaneous pain was weakened 1 week after the first injection, and disappeared 4 weeks later. He stopped taking the painkiller for several decades after 6 weeks, his mobility was increased significantly with his crutch, and walking distance and time prolonged obviously. In addition, his sleep quality, physical strength and mental state have all improved significantly. The blood triglyceride has become normal. His hair has turned black from white, and his renal function improves, and allomeric function is rejuvenated. In the next few years, he travelled overseas with friends, climbed mountains, and conducted other outdoor activities for several times, acting just like normal people, which was very impressive. 

Autologous ADSCs for chronic kidney disease 

Autologous ADSCs, featuring with "infinite" proliferation ability, multi-directional differentiation potential, hematopoietic support, immune regulation, and self-replication, can be used as ideal "seed" cells for tissue and organ damage repair caused by diseases. The kidney lesions, after autologous ADSCs enter into the patient's body, will send a certain signal for attraction, following which, numerous daughter cells the same as themselves will be produced. Such daughter cells will continue to differentiate into various types of cells, kidney tissues and renal blood vessels required by the kidney, improve local microcirculation of the kidney, reduce high pressure in the glomerulus, and relieve ischemia and hypoxia in the kidney, continuously restoring and improving blood circulation throughout the body. A certain active factor released also stimulates kidney cells to secrete erythropoietin, which can promote the production of red blood cells, thus alleviating anemia. It can also inhibit immune responses, differentiate into immune cells, and regulate the immune system function back to normal, thus achieving the step-by-step kidney repair. Relying on homing ability (targeting - targeted positioning), the damaged signals can stimulate the migration and differentiation of autologous ADSCs to damaged organs and tissues, and home to damaged lesions and repair damaged cells. 


Adress:Park House Level 1, 187 Macquarie Street, Sydney NSW

Zip code:2000

Tel:T: 1300 006 668; 02 8072 9098